Related Experiment Video
Updated: Jul 19, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa
R M Sugg1, N R Gonzales, D E Matherne
1Department of Neurology, The University of Houston Medical School, Houston, TX 77030, USA.
We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
We report myocardial injury in 20 recombinant factor VIIa (rFVIIa) treated and 110 nontreated patients with intracerebral hemorrhage. Patients were treated or received standard medical management. All received EKG and cardiac enzyme testing. Elevated troponin occurred in 20% treated vs 3% nontreated (p = 0.02). Myocardial infarction occurred in 10% vs 1% (p = 0.01). We found a significant increase in myocardial injury in rFVIIa treated patients.
More Related Videos
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Hemorrhagic Stroke l: Introduction
Myocarditis III: Medical Management
Ischemic Stroke ll: Pathophysiology

